Healthcare product manufacturer Fisher & Paykel Healthcare has reported a record half-year result, bolstered by the demand for its air-flow treatment as hospitals move away from ventilators.
The NZX-listed company has also upgraded its 2021 financial year ‘guide’ from a net profit of $365
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
